Form 4 buys and sells (codes P and S). Grants, option exercises
and conversions excluded.
Over the last 180 days, CHEVRON CORP insiders sold a net $347.8M of stock across 197 Form 4 purchases and sales, with no insider buying. Source: SEC Form 4 filings, as of 2026-10-27.
22 earlier Form 4 trades (code P or S) here by this insider (22 sales), the last on Oct 19, 2026.
The trade is 463.0% of the 8,791 shares held after it.
No other insider sold within 30 days.
1,977 funds added in the 13F quarter to Jun 30, 2026.
Insider activity: Chief Legal Officer Pate R. Hewitt sold about $9.2M of CVX under a 10b5-1 plan on Oct 20, 2026; 1,977 funds added in the latest 13F quarter.
21 earlier Form 4 trades (code P or S) here by this insider (21 sales), the last on Aug 18, 2026.
The trade is 27.3% of the 8,791 shares held after it.
No other insider sold within 30 days.
1,977 funds added in the 13F quarter to Jun 30, 2026.
Insider activity: Chief Legal Officer Pate R. Hewitt sold about $541.5K of CVX under a 10b5-1 plan on Oct 19, 2026; 1,977 funds added in the latest 13F quarter.
20 earlier Form 4 trades (code P or S) here by this insider (20 sales), the last on Mar 30, 2026.
The trade is 22.9% of the 10,794 shares held after it.
4 other insiders sold within 30 days.
1,977 funds added in the 13F quarter to Jun 30, 2026.
Insider activity: Chief Legal Officer Pate R. Hewitt sold about $506.6K of CVX on Aug 18, 2026; 4 other insiders sold within 30 days and 1,977 funds added in the latest 13F quarter.
5 earlier Form 4 trades (code P or S) here by this insider (5 sales), the last on Mar 2, 2026.
The trade is 120000.0% of the 14 shares held after it.
4 other insiders sold within 30 days.
1,977 funds added in the 13F quarter to Jun 30, 2026.
Insider activity: President, DM&C Walz Andrew Benjamin sold about $3.4M of CVX on Aug 17, 2026; 4 other insiders sold within 30 days and 1,977 funds added in the latest 13F quarter.
20 earlier Form 4 trades (code P or S) here by this insider (20 sales), the last on Aug 5, 2026.
The trade is 837.8% of the 36,619 shares held after it.
4 other insiders sold within 30 days.
1,977 funds added in the 13F quarter to Jun 30, 2026.
Insider activity: Chairman and CEO Wirth Michael K sold about $61.5M of CVX on Aug 14, 2026, the largest insider sale at the company on our record; 4 other insiders sold within 30 days and 1,977 funds added in the latest 13F quarter.
197 transactions on record
Since filing: total return from the first close after the filing to the latest close, dividend-adjusted. Not a forecast.
Context lines are counts over the filings above and returns from our own price history, never a price level. Not investment advice.
Nobody has filed for crossing 5%. That is a fact, not missing data.
CVX planned insider sales (Form 144)
Notice of intent to sell, filed before any sale
R HEWITT PATE
Filed 2026-10-19
$9.7M
Robert Hewitt Pate
Filed 2026-08-18
$508.2K
ANDREW B WALZ
Filed 2026-08-17
$3.4M
MICHAEL WIRTH
Filed 2026-08-14
$63.6M
JEFF B GUSTAVSON
Filed 2026-08-11
$2.7M
CVX mutual fund holders (N-PORT)
Funds ranked by the share of their own portfolio in this stock (N-PORT).
Strive U.S. Energy ETF
$56.9M position · as of 2026-06-30
21.8%
State Street(R) Energy Select Sector SPDR(R) ETF
$5.7B position · as of 2026-06-30
16.1%
iShares U.S. Energy ETF
$281.2M position · as of 2026-07-31
16.0%
Westwood Salient Enhanced Energy Income ETF
$14.4M position · as of 2026-07-31
14.7%
VANGUARD ENERGY INDEX FUND
$1.7B position · as of 2026-05-31
14.5%
Fidelity MSCI Energy Index ETF
$288.9M position · as of 2026-07-31
14.4%
SEC N-PORT, monthly, about 60 days late · funds ≥ $10M ·
% is the share of the fund's own portfolio
Corporate PAC
The company's PAC: committee totals only, never individual donors (FEC).
Chevron Employees Political Action Committee - Chevron Corporation
Cycle 2026 · $1,047K spent
$1.1M
Federal Election Commission, matched by the PAC's connected organisation
Executive pay vs shareholder return · Mr. Wirth
CEO pay, headline and as actually paid, against the company's
return and its chosen peers' (DEF 14A).
FY
CEO total
Actually paid
Other execs, avg
TSR
Peer TSR
2025
$26.8M
$17.7M
$9.2M
+122%
+175%
2024
$32.7M
$32.8M
$7.9M
+102%
+130%
2023
$27.4M
-$23.8M
$9.6M
+99%
+128%
2022
$24.2M
$87.4M
$8.1M
+131%
+118%
2021
$22.6M
$54.4M
$8.7M
+46%
+39%
Tagged by the company under SEC Item 402(v). Returns are
cumulative from the start of the disclosure period. Green where the company beat its own peer group.
Live price
Daily candles from TradingView, under their licence. No filings marked.
Why this name is on the desk
Insiders have filed to sell, before selling.
The record shows a net $347.8M sold by insiders over 180 days, 1,977 funds added last quarter, 3 House member(s) bought in 12 months, disclosed weeks after the trade, $238.6M in planned Form 144 sales. Each figure is a federal filing, dated the day it went public.
Ratios from the company's XBRL filings, latest filings
Revenue, TTM
$215.3B
four quarters, 2025-07-01 to 2026-06-30
Revenue, TTM CVX
FY Dec 2025
$189.0B
FY Dec 2024
$202.8B
FY Dec 2023
$200.9B
FY Dec 2022
$246.3B
FY Dec 2021
$162.5B
Jun 2026
$70.1B
Mar 2026
$48.6B
Dec 2025
$46.9B
Sep 2025
$49.7B
Jun 2025
$44.8B
Mar 2025
$47.6B
Dec 2024
$52.2B
Sep 2024
$50.7B
At each fiscal year end
Single quarter
Net margin, TTM
+9.6%
net income over revenue, 2025-07-01 to 2026-06-30
Net margin, TTM CVX
FY Dec 2025
+6.5%
FY Dec 2024
+8.7%
FY Dec 2023
+10.6%
FY Dec 2022
+14.4%
FY Dec 2021
+9.6%
Jun 2026
+17.2%
Mar 2026
+4.5%
Dec 2025
+5.9%
Sep 2025
+7.1%
Jun 2025
+5.6%
Mar 2025
+7.4%
Dec 2024
+6.3%
Sep 2024
+8.9%
At each fiscal year end
Single quarter
Free cash flow, TTM
$27.0B
operating cash flow minus capex, 2025-07-01 to 2026-06-30
Free cash flow, TTM CVX
FY Dec 2025
$16.6B
FY Dec 2024
$15.0B
FY Dec 2023
$19.8B
FY Dec 2022
$37.6B
FY Dec 2021
$21.1B
Jun 2026
$18.1B
Mar 2026
-$1.5B
Dec 2025
$5.5B
Sep 2025
$4.9B
Jun 2025
$4.9B
Mar 2025
$1.3B
Dec 2024
$4.4B
Sep 2024
$5.6B
At each fiscal year end
Single quarter
Debt to equity
0.21x
long-term 2025-12-31 (6 months older than the period end) plus current 2026-06-30; equity 2026-06-30
Debt to equity CVX
FY Dec 2025
0.27x
FY Dec 2024
0.22x
FY Dec 2023
0.16x
FY Dec 2022
0.17x
FY Dec 2021
0.24x
Jun 2026
0.21x
Mar 2026
0.25x
Dec 2025
0.27x
Sep 2025
0.12x
Jun 2025
0.18x
Mar 2025
0.16x
Dec 2024
0.22x
Sep 2024
0.16x
At each fiscal year end
Trailing four quarters at each quarter end
Cash flow to debt
1.13x
TTM operating cash flow over long-term 2025-12-31 (6 months older than the period end) plus current 2026-06-30
Cash flow to debt CVX
FY Dec 2025
0.67x
FY Dec 2024
0.96x
FY Dec 2023
1.40x
FY Dec 2022
1.81x
FY Dec 2021
0.87x
Jun 2026
1.13x
Mar 2026
0.69x
Dec 2025
0.67x
Sep 2025
1.34x
Jun 2025
1.22x
Mar 2025
1.23x
Dec 2024
0.96x
Sep 2024
1.38x
At each fiscal year end
Trailing four quarters at each quarter end
Return on equity
+12.2%
TTM net income over average of 2025-06-30 and 2026-06-30
Return on equity CVX
FY Dec 2025
+7.3%
FY Dec 2024
+11.3%
FY Dec 2023
+13.4%
FY Dec 2022
+23.8%
FY Dec 2021
+11.5%
Jun 2026
+12.2%
Mar 2026
+6.6%
Dec 2025
+7.3%
Sep 2025
+7.4%
Jun 2025
+9.0%
Mar 2025
+10.1%
Dec 2024
+11.3%
Sep 2024
+10.4%
At each fiscal year end
Trailing four quarters at each quarter end
Return on assets
+7.1%
TTM net income over average of 2025-06-30 and 2026-06-30
Return on assets CVX
FY Dec 2025
+4.2%
FY Dec 2024
+6.8%
FY Dec 2023
+8.2%
FY Dec 2022
+14.3%
FY Dec 2021
+6.5%
Jun 2026
+7.1%
Mar 2026
+3.8%
Dec 2025
+4.2%
Sep 2025
+4.4%
Jun 2025
+5.4%
Mar 2025
+6.1%
Dec 2024
+6.8%
Sep 2024
+6.4%
At each fiscal year end
Trailing four quarters at each quarter end
Return on invested capital
n/a
fewer than four consecutive quarters of operating income
Return on invested capital CVX
FY Dec 2025
n/a
FY Dec 2024
n/a
FY Dec 2023
n/a
FY Dec 2022
n/a
FY Dec 2021
n/a
Jun 2026
n/a
Mar 2026
n/a
Dec 2025
n/a
Sep 2025
n/a
Jun 2025
n/a
Mar 2025
n/a
Dec 2024
n/a
Sep 2024
n/a
At each fiscal year end
Trailing four quarters at each quarter end
Return on capital employed
n/a
fewer than four consecutive quarters of operating income
Return on capital employed CVX
FY Dec 2025
n/a
FY Dec 2024
n/a
FY Dec 2023
n/a
FY Dec 2022
n/a
FY Dec 2021
n/a
Jun 2026
n/a
Mar 2026
n/a
Dec 2025
n/a
Sep 2025
n/a
Jun 2025
n/a
Mar 2025
n/a
Dec 2024
n/a
Sep 2024
n/a
At each fiscal year end
Trailing four quarters at each quarter end
P/E, trailing
22.42x
close 2026-10-23 over four quarters of diluted EPS, 2025-07-01 to 2026-06-30
P/E, trailing CVX
FY Dec 2025
22.99x
FY Dec 2024
14.90x
FY Dec 2023
13.13x
FY Dec 2022
9.82x
FY Dec 2021
14.42x
Jun 2026
15.94x
Mar 2026
36.05x
Dec 2025
22.99x
Sep 2025
21.84x
Jun 2025
18.43x
Mar 2025
19.12x
Dec 2024
14.90x
Sep 2024
16.18x
At each fiscal year end
Trailing four quarters at each quarter end
Enterprise value
$496.9B
market value at close 2026-10-23 on 2026-06-30 shares, plus long-term 2025-12-31 (6 months older than the period end) plus current 2026-06-30, minus cash 2024-06-30
Enterprise value CVX
FY Dec 2025
$353.6B
FY Dec 2024
$289.1B
FY Dec 2023
$298.8B
FY Dec 2022
$356.8B
FY Dec 2021
$254.3B
Jun 2026
$363.7B
Mar 2026
$453.7B
Dec 2025
$353.6B
Sep 2025
$332.4B
Jun 2025
$269.7B
Mar 2025
$312.4B
Dec 2024
$289.1B
Sep 2024
$286.1B
At each fiscal year end
Trailing four quarters at each quarter end
FCF yield
+5.9%
TTM free cash flow over market value at close 2026-10-23
FCF yield CVX
FY Dec 2025
+5.4%
FY Dec 2024
+5.8%
FY Dec 2023
+7.0%
FY Dec 2022
+10.8%
FY Dec 2021
+9.3%
Jun 2026
+8.2%
Mar 2026
+3.3%
Dec 2025
+5.4%
Sep 2025
+4.9%
Jun 2025
+6.5%
Mar 2025
+4.6%
Dec 2024
+5.8%
Sep 2024
+7.1%
At each fiscal year end
Trailing four quarters at each quarter end
PEG, trailing
0.66x
P/E over trailing EPS growth of 34%: four quarters to 2026-06-30 against the four to 2025-06-30
PEG, trailing CVX
FY Dec 2025
n/a
FY Dec 2024
n/a
FY Dec 2023
n/a
FY Dec 2022
0.08x
FY Dec 2021
n/a
Jun 2026
0.47x
Mar 2026
n/a
Dec 2025
n/a
Sep 2025
n/a
Jun 2025
n/a
Mar 2025
n/a
Dec 2024
n/a
Sep 2024
n/a
At each fiscal year end
Trailing four quarters at each quarter end
Price as of 2026-10-23. Hover or tap a tile for its yearly and quarterly history.Method
TTM is four consecutive fiscal quarters; Q4 is the year minus nine months when not filed. Returns use the average of opening and closing balances. EBIT is approximated by operating income. PEG uses trailing EPS growth.
Fundamentals
Annual figures from XBRL filings. Pick a past date to see them as known then.
CVX ranks highest on financial health (74th percentile) and profitability (65th), and lowest on insider conviction (3rd), among Energy peers.
Profitability
65
Inputs
Return on equity+12.2% · 64 pct, sector of 109
Return on assets+7.1% · 66 pct, sector of 129
Return on invested capitalfewer than four consecutive quarters of operating income
Return on capital employedfewer than four consecutive quarters of operating income
Financial health
74
Inputs
Debt to equity0.21x · 69 pct, sector of 111
Cash flow to debt1.13x · 79 pct, sector of 115
Growth
37
Inputs
Revenue growth, YoY-4.6% · 37 pct, sector of 141
Backlog growth, YoYno backlog line filed, or no year-earlier backlog
Insider conviction
3
Inputs
Net Form 4 buying (codes P and S), 180d-$338.0M · 5 pct, sector of 95
Insider buyers, 180d0 · 0 pct, sector of 95
Institutional and government
50
Inputs
Funds adding, latest quarter1,977 · 100 pct, sector of 145
Congress net buyers, 365d-3 · 0 pct, sector of 31
Federal contracts, 180dno federal contracts in 180 days
Lobbying spend, 4 quartersno lobbying filings in the last four quarters
Risk and compliance
43
Inputs
Short interest, % of float+1.3% · 83 pct, sector of 167
Recalls per $1B revenue, 3ynot measured for this sector, almost no peer has an event
EPA cases per $1B revenue, 5y0.01 per $1B · 13 pct, sector of 109
New text in Risk Factors, latest 10-K+13.6% · 33 pct, sector of 120
1 not measured: US patents
US patents needs 1 of 2 inputs, 0 present: patent data not loaded yet
6 of 7 axes scored. Each is a percentile against sector peers (all companies when the sector is thin); higher is better. An unscored axis is unmeasured, not low. How it is scored
CVX filings, in plain words
Are Chevron insiders buying or selling CVX?
In the 180 days to 2026-10-27, Chevron insiders were net sellers, a net $347.8M across purchases and sales reported on Form 4, by 5 sellers.
Have members of Congress traded CVX?
Yes. In the year to 2026-10-27, 3 House members disclosed buying CVX and 6 House members disclosed selling it; the latest on record is a sale by Kevin Hern dated 2026-09-23.
Are there planned insider sales of CVX?
Yes. 8 Form 144 notices of planned insider sales were filed in the 90 days to 2026-10-27, covering $238.6M of stock; the latest, by R HEWITT PATE, was filed 2026-10-19.
Read the full summary
In the 180 days to 2026-10-27, Chevron insiders were net sellers of CVX, a net $347.8M across purchases and sales reported on Form 4 by 5 sellers. 8% of the 26 insider sales were made under a Rule 10b5-1 plan; the rest were not flagged as planned. In the year to 2026-10-27, 3 members of Congress disclosed buying CVX and 6 members disclosed selling it; the latest on record is a sale by Kevin Hern dated 2026-09-23. Insiders filed 8 Form 144 notices of intent to sell in the 90 days to 2026-10-27, covering $238.6M of stock. Each figure is counted from SEC and House filings as of 2026-10-27, dated the day the filing was made public.
Explore insider trading and ownership data
Every company we track, ranked by each kind of filing
No password to create and no card required. We store your email address, your watchlist and your preferences, nothing else.
PRIVACY & COOKIES
We track filings, not you.
Essential cookies keep you signed in and remember this choice.
Google Analytics 4 and Microsoft Clarity load only if you allow them here; they
count visits and record how pages are used. We run no advertising and never sell
data. Details in the privacy policy. Change this any time
via "Cookie settings" in the footer.